{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:46:46Z","timestamp":1792417606975,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.neuropharm.2008.10.016","type":"journal-article","created":{"date-parts":[[2008,11,22]],"date-time":"2008-11-22T04:37:03Z","timestamp":1227328623000},"page":"580-589","source":"Crossref","is-referenced-by-count":80,"title":["Nimodipine protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation"],"prefix":"10.1016","volume":"56","author":[{"given":"Yachen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongming","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2008.10.016_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-4615-4685-6_10","article-title":"The role of microglia and astrocytes in CNS immune surveillance and immunopathology","volume":"468","author":"Aloisi","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","article-title":"Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism","volume":"76","author":"Block","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0197-0186(95)00141-7","article-title":"Peripheral administration of lipopolysaccharide induces activation of microglial cells in rat brain","volume":"29","author":"Buttini","year":"1996","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib4","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1046\/j.1471-4159.1998.70041584.x","article-title":"Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system","volume":"70","author":"Casta\u00f1o","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib5","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.4049\/jimmunol.151.3.1473","article-title":"Neuroprotective role of IL-4 against activated microglia","volume":"151","author":"Chao","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/glia.1070","article-title":"Characterization of a novel brain-derived microglial cell line isolated from neonatal rat brain","volume":"35","author":"Cheepsunthorn","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2008.10.016_bib7","doi-asserted-by":"crossref","first-page":"C1650","DOI":"10.1152\/ajpcell.1994.266.6.C1650","article-title":"K+ modulation of microglial superoxide production: involvement of voltage-gated Ca+ channels","volume":"266","author":"Cloton","year":"1994","journal-title":"Am. J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/glia.440070113","article-title":"Microglia and cytokines in neurological disease: with special reference to AIDS and Alzheimer's disease","volume":"7","author":"Dickson","year":"1993","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2008.10.016_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1152\/ajpcell.1998.275.2.C327","article-title":"Ion channels in microglia (brain macrophages)","volume":"275","author":"Eder","year":"1998","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib10","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neurobiolaging.2005.02.006","article-title":"Nimodipine selectively stimulated \u03b2-amyloid 1\u201342 secretion by a mechanism independent of calcium influx blockage","volume":"27","author":"Facchinetti","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2008.10.016_bib11","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/glia.20412","article-title":"Functional role of calcium signals for microglial function","volume":"54","author":"F\u00e4rber","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2008.10.016_bib12","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0891-5849(98)00293-7","article-title":"Neuroinflammatory processes are important in neurodegenerative diseases: a hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development","volume":"26","author":"Floyd","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib13","first-page":"439","article-title":"Clinical findings with nimodipine in dementia: test of the calcium hypothesis","volume":"46","author":"Fritze","year":"1995","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib14","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1046\/j.1471-4159.2002.00928.x","article-title":"Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease","volume":"81","author":"Gao","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0165-3806(01)00315-7","article-title":"Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-\u03b1, interleukin-1\u03b2 and nitric oxide","volume":"133","author":"Gayle","year":"2002","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/(SICI)1098-1136(199710)21:2<253::AID-GLIA8>3.0.CO;2-7","article-title":"Increase of intracellular free Ca2+ in microglia activated by prion protein fragment","volume":"21","author":"Herms","year":"1997","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2008.10.016_bib17","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1161\/hs1001.096009","article-title":"Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review","volume":"32","author":"Horn","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2008.10.016_bib18","first-page":"309","article-title":"Drug action and cellular calcium regulation","volume":"16","author":"Janis","year":"1987","journal-title":"Adv. Drug Res."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(97)00204-X","article-title":"Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron\/glia cultures","volume":"85","author":"Jeohn","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","article-title":"Microglia: a sensor for pathological events in the CNS","volume":"19","author":"Kreutzberg","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00003495-198937050-00004","article-title":"Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease","volume":"37","author":"Langley","year":"1989","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2008.10.016_bib22","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.4049\/jimmunol.150.7.2659","article-title":"Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta","volume":"150","author":"Lee","year":"1993","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.neuropharm.2008.10.016_bib50","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.expneurol.2006.01.010","article-title":"Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally","volume":"199","author":"Ling","year":"2006","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.neuropharm.2008.10.016_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.035048","article-title":"Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention","volume":"304","author":"Liu","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0022-3565(24)39275-4","article-title":"Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation","volume":"293","author":"Liu","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib24","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1749-6632.2002.tb04077.x","article-title":"Role of nitric oxide in inflammation-mediated neurodegeneration","volume":"962","author":"Liu","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib26","first-page":"165","article-title":"Role of calcium on interleukin-1 production by monocytes: its relevance during T cell proliferation","volume":"10","author":"Mahe","year":"1991","journal-title":"Lymphokine Cytokine Res."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","article-title":"The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases","volume":"21","author":"McGeer","year":"1995","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib30","first-page":"83","article-title":"Inflammation in Parkinson's disease","volume":"86","author":"McGeer","year":"2001","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/exnr.2001.7688","article-title":"Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons","volume":"169","author":"McGuire","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0306-4522(98)00491-6","article-title":"Effects of ATP and elevated K+ on K+ currents and intracellular Ca2+ in human microglia","volume":"91","author":"McLarnon","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2008.10.016_bib27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0006-8993(86)91236-9","article-title":"Inhibition of electrically induced seizures by a dihydropyridine calcium channel blocker","volume":"384","author":"Meyer","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib33","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/BF01809745","article-title":"Nimodipine in traumatic subarachnoid haemorrhage: a re-analysis of the HIT I and HIT II trial","volume":"138","author":"Murray","year":"1996","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/glia.10152","article-title":"Calcium signaling in microglial cells","volume":"40","author":"M\u00f6ller","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2008.10.016_bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/oxfordjournals.jbchem.a002969","article-title":"Microglia: activation and their significance in the central nervous system","volume":"130","author":"Nakajima","year":"2001","journal-title":"J. Biochem."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib51","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1248\/bpb.25.945","article-title":"Regulating factors for microglial activation","volume":"25","author":"Nakamura","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0168-0102(97)00033-3","article-title":"Induction of major histocompatibility class II antigen on microglial cells in postnatal and adult rats following intraperitoneal injections of lipopolysaccharide","volume":"28","author":"Ng","year":"1997","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nrn752","article-title":"Innate immunity: the missing link in neuroprotection and neurodegeneration?","volume":"3","author":"Nguyen","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib37","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3171\/jns.1983.59.6.0933","article-title":"Calcium channel antagonist binding sites labeled by 3H-nimodipine in human brain","volume":"59","author":"Peroutka","year":"1983","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0009-8981(99)00246-6","article-title":"A microtiter plate assay for superoxide dismutase using a water-soluble tetrazolium salt (WST-1)","volume":"293","author":"Peskin","year":"2000","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.neuropharm.2008.10.016_bib40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1124\/jpet.106.106351","article-title":"Interleukin-10 protects lipopolysaccharide induced neurotoxicity in primary midbrain cultures by inhibiting the function of NADPH oxidase","volume":"319","author":"Qian","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib39","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.4049\/jimmunol.179.2.1198","article-title":"Microglia-mediated neurotoxicity is inhibited by morphine through an opioid receptor-independent reduction of NADPH oxidase activity","volume":"179","author":"Qian","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib41","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1074\/jbc.M307657200","article-title":"NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia","volume":"279","author":"Qin","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib42","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0197-4580(90)90120-O","article-title":"Aging and cognition: facilitation of recent memory in aged nonhuman primates by nimodipine","volume":"11","author":"Sandin","year":"1990","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2008.10.016_bib43","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0006-8993(89)90078-4","article-title":"Production of tumor necrosis factor-\u03b1 by microglia and astrocytes in culture","volume":"491","author":"Sawada","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib44","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1096\/fasebj.3.7.2565839","article-title":"Pharmacological basis for the use of nimodipine in central nervous system disorders","volume":"3","author":"Scriabine","year":"1989","journal-title":"FASEB J"},{"key":"10.1016\/j.neuropharm.2008.10.016_bib45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/glia.440010502","article-title":"Functional plasticity of microglia: a review","volume":"1","author":"Streit","year":"1993","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2008.10.016_bib46","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1006\/bbrc.1993.2323","article-title":"Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages","volume":"196","author":"Szab\u00f3","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib47","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1474-4422(06)70582-8","article-title":"Effect of nimodipine on outcome in patients with traumatic subarachnoid haemorrhage: a systematic review","volume":"12","author":"Vergouwen","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib48","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1471-4159.1994.62010372.x","article-title":"Ca2+ channel blockers attenuate beta-amyloid peptide toxicity to cortical neurons in culture","volume":"62","author":"Weiss","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.10.016_bib49","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1523\/JNEUROSCI.22-09-03484.2002","article-title":"Peroxynitrite mediates neurotoxicity of amyloid \u03b2-peptide1\u201342- and lipopolysaccharide-activated microglia","volume":"22","author":"Xie","year":"2002","journal-title":"J. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808005029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808005029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T23:23:41Z","timestamp":1738538621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390808005029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0028390808005029"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2008.10.016","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}